SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-07-000965
Filing Date
2007-01-29
Accepted
2007-01-29 15:21:35
Documents
4
Period of Report
2007-01-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y29622e8vk.htm 8-K 13129
2 EX-10.1: LETTER AGREEMENT y29622exv10w1.htm EX-10.1 7550
3 EX-99.1: PRESS RELEASE y29622exv99w1.htm EX-99.1 12566
4 GRAPHIC y29622y2962201.gif GRAPHIC 2591
  Complete submission text file 0000950123-07-000965.txt   38659
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 07560710
SIC: 2835 In Vitro & In Vivo Diagnostic Substances